DK1503803T3 - Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps - Google Patents

Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps

Info

Publication number
DK1503803T3
DK1503803T3 DK03752788T DK03752788T DK1503803T3 DK 1503803 T3 DK1503803 T3 DK 1503803T3 DK 03752788 T DK03752788 T DK 03752788T DK 03752788 T DK03752788 T DK 03752788T DK 1503803 T3 DK1503803 T3 DK 1503803T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
composition containing
injectable pharmaceutical
containing ethanol
disc prolapse
Prior art date
Application number
DK03752788T
Other languages
Danish (da)
English (en)
Inventor
Jacques Theron
Original Assignee
Jacques Theron
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacques Theron filed Critical Jacques Theron
Application granted granted Critical
Publication of DK1503803T3 publication Critical patent/DK1503803T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Massaging Devices (AREA)
DK03752788T 2002-05-07 2003-05-07 Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps DK1503803T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0205819A FR2839450B1 (fr) 2002-05-07 2002-05-07 Preparation medicamenteuse notamment pour le traitement des hernies discales
PCT/FR2003/001412 WO2003097108A1 (fr) 2002-05-07 2003-05-07 Preparation medicamenteuse notamment pour le traitement des hernies discales

Publications (1)

Publication Number Publication Date
DK1503803T3 true DK1503803T3 (da) 2008-11-10

Family

ID=29286406

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03752788T DK1503803T3 (da) 2002-05-07 2003-05-07 Injicerbar farmaceutisk sammensætning indeholdende ethanol til at behandle diskusprolaps

Country Status (15)

Country Link
US (3) US20070116647A1 (zh)
EP (1) EP1503803B1 (zh)
CN (1) CN100402020C (zh)
AT (1) ATE402719T1 (zh)
AU (1) AU2003262617A1 (zh)
CA (1) CA2498976C (zh)
CY (1) CY1108413T1 (zh)
DE (1) DE60322530D1 (zh)
DK (1) DK1503803T3 (zh)
ES (1) ES2309334T3 (zh)
FR (1) FR2839450B1 (zh)
HK (1) HK1081849A1 (zh)
PT (1) PT1503803E (zh)
SI (1) SI1503803T1 (zh)
WO (1) WO2003097108A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2839450B1 (fr) * 2002-05-07 2006-04-07 Aboville Marc D Preparation medicamenteuse notamment pour le traitement des hernies discales
FR2891461B1 (fr) * 2005-09-30 2010-09-03 Jacques Theron Preparation medicamenteuse visqueuse injectable comprenant de l'ethanol et un compose liposoluble opaque aux rayons x.
EP3679140B1 (en) 2017-09-08 2022-11-16 MiNA Therapeutics Limited Stabilized cebpa sarna compositions and methods of use
TW201920669A (zh) 2017-09-08 2019-06-01 英商美納治療公司 ＨＮＦ４ａ ｓａＲＮＡ組成物和使用方法
EP4017539A1 (en) 2019-08-19 2022-06-29 MiNA Therapeutics Limited Oligonucleotide conjugate compositions and methods of use
CN117222405A (zh) * 2021-03-04 2023-12-12 苏州医本生命科技有限公司 一种含乙醇的药物组合物及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2162028A (en) * 1938-06-25 1939-06-13 Pittsburgh Plate Glass Co Cellulose ether coating composition
US2903396A (en) * 1957-05-08 1959-09-08 Ciba Pharm Prod Inc Therapeutic compositions and method for treating parkinsonism
EP0304403A3 (de) * 1987-08-21 1990-12-12 Ciba-Geigy Ag Kunststoffzusammensetzung mit Supraleitern
JPH02157029A (ja) * 1988-12-09 1990-06-15 Dainippon Pharmaceut Co Ltd アニオン系界面活性剤含有組成物の安定化
US5830178A (en) * 1996-10-11 1998-11-03 Micro Therapeutics, Inc. Methods for embolizing vascular sites with an emboilizing composition comprising dimethylsulfoxide
US6476070B2 (en) * 1997-09-11 2002-11-05 Provasis Therapeutics Inc. Compositions useful for remodeling body spaces
US6015541A (en) * 1997-11-03 2000-01-18 Micro Therapeutics, Inc. Radioactive embolizing compositions
US6150022A (en) * 1998-12-07 2000-11-21 Flex Products, Inc. Bright metal flake based pigments
EP1180051A4 (en) * 1999-05-21 2004-06-30 Micro Therapeutics Inc METHODS FOR EMBOLIZING BLOOD VESSELS WITH AN EMBOLIZING CONNECTION
JP5148030B2 (ja) * 1999-05-21 2013-02-20 タイコ ヘルスケア グループ リミテッド パートナーシップ 新規の高粘度塞栓形成組成物
US6355058B1 (en) * 1999-12-30 2002-03-12 Advanced Cardiovascular Systems, Inc. Stent with radiopaque coating consisting of particles in a binder
US20020115904A1 (en) * 2001-02-21 2002-08-22 Brooke Ren Magnetically controllable embolic materials
FR2839450B1 (fr) * 2002-05-07 2006-04-07 Aboville Marc D Preparation medicamenteuse notamment pour le traitement des hernies discales

Also Published As

Publication number Publication date
CN1665546A (zh) 2005-09-07
US20130143970A1 (en) 2013-06-06
FR2839450A1 (fr) 2003-11-14
WO2003097108A1 (fr) 2003-11-27
CA2498976A1 (fr) 2003-11-27
CY1108413T1 (el) 2014-02-12
EP1503803A1 (fr) 2005-02-09
CN100402020C (zh) 2008-07-16
EP1503803B1 (fr) 2008-07-30
FR2839450B1 (fr) 2006-04-07
ATE402719T1 (de) 2008-08-15
CA2498976C (fr) 2011-09-06
US20070116647A1 (en) 2007-05-24
HK1081849A1 (en) 2006-05-26
DE60322530D1 (de) 2008-09-11
ES2309334T3 (es) 2008-12-16
PT1503803E (pt) 2008-10-16
AU2003262617A1 (en) 2003-12-02
US20100329991A1 (en) 2010-12-30
US8153696B2 (en) 2012-04-10
SI1503803T1 (sl) 2008-12-31

Similar Documents

Publication Publication Date Title
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
AU9163701A (en) Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
RS52110B (en) DIPEPTIDIL PEPTIDASE INHIBITORS FOR TREATMENT OF DIABETES
DK1797053T3 (da) Phenothiazinium-forbindelse til sårheling
NO20053150D0 (no) System for administrasjon av medisin.
ATE367152T1 (de) Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
ECSP066860A (es) Formulaciones de matriz oral que comprenden licarbazepina
CY1108413T1 (el) Ενεσιμη φαρμακευτικη συνθεση που περιλαμβανει αιθανολη για την αγωγη των δισκοπαθειων
HRP20070291T3 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
WO2003063824A3 (en) Pharmaceutical composition
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
UY28148A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
ITMI20041245A1 (it) Composizioni farmaceutiche iniettabnili comprendenti diclofenac sodico e b-ciclodestrina
AR039232A1 (es) Una formulacion farmaceutica que comprende al menos un compuesto seleccionado del grupo formado por hipnoticos no barbituricos y no benzodiacepinicos, y melatonina
WO2005058824A3 (en) N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprote in b
EA200501565A1 (ru) Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса
EA200601015A1 (ru) Пероральные композиции дезоксипеганина и их применение
SE0203817D0 (sv) New composition
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
BR0110669A (pt) Composição oral.
ITTO20001109A0 (it) Composizione farmaceutica per il trattamento anti m. ulcerans.
ITMI20032417A1 (it) Composizione farmaceutica particolarmente per uso dermatologico.
IT1315249B1 (it) Composizioni farmaceutiche contenenti farmaci antiinfiammatori
ITTO20020352A0 (it) ,,composizione farmaceutica anti-depressiva contenente estratto di polygala,,.
ITMI20011390A1 (it) Formulazioni farmaceutiche per ormoni tiroidei.